🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China flag China · Delayed Price · Currency is CNY
10.89
-0.43 (-3.80%)
Nov 20, 2026, 3:04 PM CST

SHE:002020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
336.27530.71316.271,4611,5481,561
Short-Term Investments
948.53-----
Trading Asset Securities
818.09318.96827.66150.96366.89422.4
Cash & Short-Term Investments
2,103849.671,1441,6121,9151,983
Cash Growth
217.27%-25.72%-29.03%-15.85%-3.41%-8.38%
Accounts Receivable
729.13881.12852.02612.58509.57510.67
Other Receivables
28.7740.4655.2651.4459.13103.81
Receivables
757.9921.58907.27664.02568.7614.47
Inventory
816.03766.15792.72652.69773.7677.69
Prepaid Expenses
-3.223.363.72.520.81
Other Current Assets
119.71760.1957.5421.5620.8817.82
Total Current Assets
3,7973,3012,9053,3543,2813,294
Property, Plant & Equipment
2,1772,2812,1882,3001,6321,297
Long-Term Investments
535.731,4882,1611,1241,134882.21
Goodwill
315.71335.6348.48348.48348.48348.48
Other Intangible Assets
424.51431.89382.26401.26418.59157
Long-Term Deferred Tax Assets
75.3479.2383.5680.9875.1168.64
Long-Term Deferred Charges
28.2338.9358.7321.226.7155.95
Other Long-Term Assets
762.95167.59351.9356.72446.73443.95
Total Assets
8,1168,1248,4797,9877,3636,547

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
602.71666.34880.79941.16719.12449.79
Accrued Expenses
165.32225.72198.28206.39187.72189.47
Short-Term Debt
205.68284.39281.36279.09238.58148.33
Current Portion of Long-Term Debt
----0.050.27
Current Portion of Leases
11.416.6313.311.8614.6914.66
Current Income Taxes Payable
69.9141.6589.1844.359.9950.25
Current Unearned Revenue
47.5456.4556.4853.3581.0147.61
Other Current Liabilities
624.72625.72615.12538.61514.23521.88
Total Current Liabilities
1,7271,9072,1352,0751,8151,422
Long-Term Debt
-----0.04
Long-Term Leases
27.4922.6323.1331.2342.9830.62
Long-Term Unearned Revenue
258.51263.91264.59268.81270.6128.73
Long-Term Deferred Tax Liabilities
56.8958.9654.3368.459.6865.44
Other Long-Term Liabilities
0.720.861.193.21.940.74
Total Liabilities
2,0712,2532,4782,4462,1911,648

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
861.03861.03861.03861.03861.03905.32
Additional Paid-In Capital
1,7421,7231,7231,7231,7202,236
Retained Earnings
4,0833,8413,3682,9142,5542,150
Treasury Stock
-698.75-608.78----437.62
Comprehensive Income & Other
17.9316.6517.1713.8611.318.05
Total Common Equity
6,0055,8335,9705,5125,1464,862
Minority Interest
39.4137.2332.0427.7825.8537.72
Shareholders' Equity
6,0455,8706,0025,5405,1724,899
Total Liabilities & Equity
8,1168,1248,4797,9877,3636,547

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
244.58313.65317.79322.18296.3193.92
Net Cash (Debt)
1,858536.02826.131,2901,6191,789
Net Cash Growth
345.53%-35.12%-35.94%-20.35%-9.51%-4.00%
Net Cash Per Share
2.280.650.961.501.882.19
Filing Date Shares Outstanding
813.79813.76861.03861.03861.03861.03
Total Common Shares Outstanding
813.79813.76861.03861.03861.03861.03
Working Capital
2,0691,394770.261,2791,4661,872
Book Value Per Share
7.387.176.936.405.985.65
Tangible Book Value
5,2655,0665,2394,7634,3794,356
Tangible Book Value Per Share
6.476.226.085.535.095.06
Land
----0.21--
Buildings
-1,7971,6291,388934.82889.16
Machinery
-1,8401,7541,4121,219946.45
Construction In Progress
-52.7113.62482.06284.91161.34